Quantitative Systematic Strategies’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Quantitative Systematic Strategies’s Portfolio KNSA Stock Details KNSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-17,669	Closed	-$312K	–	691
2020 Q4	$312K	Buy	17,669 +5,246	+42%	+$92.2K	0.04%	475
2020 Q3	$190K	Buy	+12,423	New	+$233K	0.03%	528
2020 Q1	–	Sell	-12,051	Closed	-$133K	–	401
2019 Q4	$133K	Buy	+12,051	New	+$105K	0.02%	514
2018 Q3	–	Sell	-20,055	Closed	-$348K	–	711
2018 Q2	$348K	Buy	+20,055	New	+$363K	0.06%	430

Other funds holding KNSA

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Quantitative Systematic Strategies's KNSA Position: Q1 2021 in Review

Quantitative Systematic Strategies sold out of Kiniksa Pharmaceuticals (KNSA) in Q1 2021, closing a stake of 17,669 shares — an estimated $312K sold.

Quantitative Systematic Strategies first reported a position in KNSA in Q2 2018 and held it in 4 quarters. The position peaked at $348K in Q2 2018. 105 funds tracked by Wall St. Rank hold KNSA as of Q1 2021.

Quantitative Systematic Strategies reported no remaining Kiniksa Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
Quantitative Systematic Strategies sold 17,669 Kiniksa Pharmaceuticals shares in Q1 2021, an estimated $312K.
Quantitative Systematic Strategies first reported a position in Kiniksa Pharmaceuticals in Q2 2018 and held it in 4 quarters.
Quantitative Systematic Strategies's Kiniksa Pharmaceuticals position peaked at $348K in Q2 2018.
105 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q1 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2021, filed 6 May 2021.